A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus after liver transplantation. A new study pinpoints certain ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

The median follow-up was 11.0 years for patients with HB-HCC and 10.1 years for those with HC-HCC. Recurrence occurred in 39 (59%) patients with HB-HCC and 282 (80%) with HC-HCC. The odds ratio for ...

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial Prospective collection of ...

New data presented today at The International Liver Congress 2015, supports the use of sofosbuvir (SOF)- and daclatasvir (DCV)-based regimens in patients with recurrence of the hepatitis C virus (HCV) ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A potential first-in-class investigational microbiome ...

A pair of posters presented at Digestive Disease Week 2022 showed the efficacy of an investigational biotherapeutic in preventing Clostridioides difficile infection recurrence and restoring the ...

Researchers analyzed data from more than 4,000 C. diff patients, 10.1 percent of whom developed a recurrent CDI. Sign up for our FREE E-Weekly for more coverage like this sent to your inbox! Patients ...

Ticagrelor and aspirin is the preferred combination for reducing the risk of recurrent stroke in clopidogrel nonresponders, but according to post hoc analysis of the CHANCE-2 trial, patients with ...

Correspondence to Dr Noel Pollock, British Athletics Medical Team, Hospital of St John & St Elizabeth, 60 Grove End Road, London NW8 9NH, UK; npollock{at}britishathletics.org.uk Background The British ...